Quote:
Originally Posted by soccertese
just wonder why they think there's a market for a slightly better controlled release sinemet? i don't think they went head to head against STALEVO. maybe there is a population that can't tolerate COMTAN or other adjuncts to C/L?
it's going to be expensive, wonder how insurance companies will reimburse with cheaper STALEVO? i'm only taking C/L, temporarily had extreme wearing off after bedtime where pain from back and abdomen rigidity woke me up and i had to take a C/L to relieve the rigidity. strangely episode lasted 3 days and now back to "normal". so i'd buy a pill that lasted longer that didn't contain COMTAN that i could take just at night but i don't think RYTARY is even close.
|
If there was ever a drug that needed to be licensed (or sold) out to another manufacturer, it's RYTARY. Even if they eventually receive final FDA approval to launch the drug, who would want to trust Impax on the production quality.